AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK

AstraZeneca has logged a last-minute victory—for now—in its executive tug of war with GSK.

Just hours before outgoing AZ exec Chris Sheldon was set to take up his post at crosstown rival GSK, AZ has blocked the move in a London court. Wednesday, a High Court judge granted AZ an injunction in the unusual legal battle, as reported by the Financial Times, Bloomberg and others.